Quest Diagnostics Incorporated
DGX
$175.13
$1.370.79%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 220.00M | 222.00M | 226.00M | 229.00M | 194.00M |
| Total Depreciation and Amortization | 140.00M | 135.00M | 125.00M | 117.00M | 116.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 44.00M | 74.00M | 47.00M | 20.00M | 30.00M |
| Change in Net Operating Assets | -90.00M | 33.00M | -42.00M | -6.00M | -186.00M |
| Cash from Operations | 314.00M | 464.00M | 356.00M | 360.00M | 154.00M |
| Capital Expenditure | -117.00M | -123.00M | -106.00M | -92.00M | -104.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -383.00M | -1.53B | -106.00M | -142.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.00M | 4.00M | 6.00M | -2.00M | 33.00M |
| Cash from Investing | -115.00M | -502.00M | -1.63B | -200.00M | -213.00M |
| Total Debt Issued | 215.00M | 0.00 | 1.85B | -- | -- |
| Total Debt Repaid | -600.00M | -1.00M | -1.00M | -301.00M | -- |
| Issuance of Common Stock | 29.00M | 21.00M | 24.00M | 16.00M | 12.00M |
| Repurchase of Common Stock | -42.00M | -151.00M | -1.00M | 0.00 | -23.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -84.00M | -84.00M | -84.00M | -84.00M | -79.00M |
| Other Financing Activities | -79.00M | 45.00M | -14.00M | 6.00M | -63.00M |
| Cash from Financing | -561.00M | -170.00M | 1.77B | -363.00M | -153.00M |
| Foreign Exchange rate Adjustments | 1.00M | -7.00M | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -361.00M | -215.00M | 493.00M | -203.00M | -212.00M |